日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Illuminating and mitigating the evolving impacts of COVID-19 on ethnocultural communities: a participatory action mixed-methods study

阐明并减轻 COVID-19 对族裔文化社区不断变化的影响:一项参与式行动混合方法研究

Campbell-Scherer, Denise; Chiu, Yvonne; Ofosu, Nicole Naadu; Luig, Thea; Hunter, Karen Heather; Jabbour, Badi; Farooq, Sauleha; Mahdi, Ali; Gayawira, Aline; Awasis, Fransiska; Olokude, Funke; Goa, Hannah; Syed, Hina; Sillito, Judy; Yip, Lydia; Belle, Lyn; Akot, Mawien; Nutter, Monique; Farhat, Nadia; Wang, Yan; Jalal, Niga; Khalif, Saida; Chapagain, Shiva; Fernandez, Stephanie; Azarcon, Susan; Hama, Zhewar

Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension

氧化脂质介质导致促炎性高密度脂蛋白,这是特发性及相关类型肺动脉高压发病机制中的结果

David J Ross, Greg Hough, Susan Hama, Jamil Aboulhosn, John A Belperio, Rajan Saggar, Brian J Van Lenten, Abbas Ardehali, Mansoureh Eghbali, Srinivasa Reddy, Alan M Fogelman, Mohamad Navab

Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis

对氧磷酶 2 缺乏会改变线粒体功能并加剧动脉粥样硬化的发展

Asokan Devarajan, Noam Bourquard, Susan Hama, Mohamad Navab, Victor R Grijalva, Susan Morvardi, Catherine F Clarke, Laurent Vergnes, Karen Reue, John F Teiber, Srinivasa T Reddy

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally

肠道可能是 apoA-I 模拟肽 4F 的主要作用位点,无论是皮下给药还是口服给药

Mohamad Navab, Srinivasa T Reddy, G M Anantharamaiah, Satoshi Imaizumi, Greg Hough, Susan Hama, Alan M Fogelman

Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels

丝裂原活化蛋白激酶磷酸酶-1 缺乏可降低单核细胞趋化蛋白-1 水平,从而减轻载脂蛋白 E 基因缺失小鼠的动脉粥样硬化

Satoshi Imaizumi, Victor Grijalva, Saul Priceman, Lily Wu, Feng Su, Robin Farias-Eisner, Susan Hama, Mohamad Navab, Alan M Fogelman, Srinivasa T Reddy

Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids

氧化磷脂 11D:一种与胆固醇和氧化磷脂结合的抗炎肽

Piotr Ruchala, Mohamad Navab, Chun-Ling Jung, Susan Hama-Levy, Ewa D Micewicz, Hai Luong, Jonathan E Reyles, Shantanu Sharma, Alan J Waring, Alan M Fogelman, Robert I Lehrer

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids

一种口服递送全 L-氨基酸合成载脂蛋白模拟肽的新方法

Mohamad Navab, Piotr Ruchala, Alan J Waring, Robert I Lehrer, Susan Hama, Greg Hough, Mayakonda N Palgunachari, G M Anantharamaiah, Alan M Fogelman

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

抗炎载脂蛋白 A-I 模拟肽与氧化脂质的结合亲和力比人类载脂蛋白 A-I 高得多

Brian J Van Lenten, Alan C Wagner, Chun-Ling Jung, Piotr Ruchala, Alan J Waring, Robert I Lehrer, Andrew D Watson, Susan Hama, Mohamad Navab, G M Anantharamaiah, Alan M Fogelman